How tumor-derived GABA disables tumor TLSs and drives anti-PD-1 resistance in cancer
How CD95 keeps NF-κB switched off in triple-negative breast cancer — and what its loss unleashes
How CD95/Fas helps triple-negative breast cancer escape NK-cell control in preclinical models
